Tenax Therapeutics (TENX) Capital Expenditures (2016 - 2017)
Historic Capital Expenditures for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $1.0.
- Tenax Therapeutics' Capital Expenditures changed N/A to $1.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $4537.0, marking a year-over-year increase of 5731.62%. This contributed to the annual value of $5252.0 for FY2021, which is 5048.71% up from last year.
- Per Tenax Therapeutics' latest filing, its Capital Expenditures stood at $1.0 for Q4 2017.
- Tenax Therapeutics' Capital Expenditures' 5-year high stood at $1.8 million during Q1 2014, with a 5-year trough of $1.0 in Q4 2017.
- Over the past 5 years, Tenax Therapeutics' median Capital Expenditures value was $10461.0 (recorded in 2015), while the average stood at $715164.8.
- Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 9976.33% in 2015, then surged by 1345.35% in 2017.
- Over the past 5 years, Tenax Therapeutics' Capital Expenditures (Quarter) stood at $1.8 million in 2013, then rose by 0.55% to $1.8 million in 2014, then crashed by 99.07% to $16688.0 in 2015, then crashed by 82.72% to $2884.0 in 2016, then crashed by 99.97% to $1.0 in 2017.
- Its last three reported values are $1.0 in Q4 2017, $1264.0 for Q3 2017, and $3272.0 during Q1 2017.